Early versus late discontinuation of oxygen in preterm or low birth weight infants
- PMID: 10796243
- PMCID: PMC8406905
- DOI: 10.1002/14651858.CD001076
Early versus late discontinuation of oxygen in preterm or low birth weight infants
Update in
-
Early versus late discontinuation of oxygen in preterm or low birth weight infants.Cochrane Database Syst Rev. 2001;(4):CD001076. doi: 10.1002/14651858.CD001076. Cochrane Database Syst Rev. 2001. PMID: 11687095
Abstract
Background: This section is under preparation and will be included in the next issue.
Objectives: In preterm or low birth weight infants, does early versus late weaning from supplementary oxygen influence mortality, retinopathy of prematurity, lung function, growth or development?
Search strategy: The standard search strategy of the Neonatal Review Group was used. This included searches of the Oxford Database of Perinatal Trials, MEDLINE, previous reviews including cross references, abstracts, conferences and symposia proceedings, expert informants, journal handsearching mainly in the English language. An additional literature search of the MEDLINE, EMBASE, and CINAHL databases was conducted in order to locate any trials in addition to those provided by the Cochrane Controlled Trials Register (CENTRAL/CCTR).
Selection criteria: All trials utilising random or quasi-random patient allocation, in which early weaning was compared with late discontinuation of supplemental oxygen in preterm or low birth weight infants, were eligible for inclusion.
Data collection and analysis: The methodological quality of the one eligible trial was assessed independently by each author for the degree of selection, performance, attrition and detection bias. Data regarding clinical outcomes including mortality, retinopathy of prematurity, and long term growth and development were extracted and reviewed independently by each author. Results were compared and differences resolved as required. Data analysis was conducted according to the standards of the Cochrane Neonatal Review Group.
Main results: In the single eligible trial of 99 infants with birthweights less than 1650g, there were no significant differences in neonatal death rates or retrolental fibroplasia (any grade or severe) for all infants, or among infants with birth weights of less than 1000g. No other outcome measures specified a priori as clinically meaningful were reported in enough detail or with satisfactory follow-up rates to include in the analysis (early death; chronic lung disease; and long term growth, development, lung or visual function).
Reviewer's conclusions: The results of this systematic review do not provide strong evidence for either the benefits or harms of early oxygen weaning in preterm/LBW infants. Future research should be directed toward addressing the question of what are the most appropriate target levels of oxygenation, in both the early and late neonatal periods, rather than whether oxygen should be weaned early or late.
Conflict of interest statement
The authors of this review are currently conducting a randomized, controlled trial of the effect of higher versus standard oxygen saturation targeting on long term growth and development of preterm infants.
References
References to studies included in this review
Engle 1955 {published data only}
-
- Engle MA, Baker DH, Baras I, Freemond A, Laupus WE, Norton EW. Oxygen administration and retrolental fibroplasia. American Journal of Diseases of Children 1955;89:399‐413. - PubMed
-
- Engle MA, Levine SZ. Response of small premature infants to restriction of supplementary oxygen. American Journal of Diseases of Children 1955;89:316‐24. - PubMed
References to studies excluded from this review
Simoes 1997 {published data only}
-
- Simoes EAF, Rosenberg AA, King SJ, Groothius JR. Room air challenge: prediction for successful weaning of oxygen‐dependent infants. Journal of Perinatology 1997;17:125‐9. - PubMed
Additional references
Avery 1960
-
- Avery ME, Oppenheimer EH. Recent increase in mortality from hyaline membrane disease. Journal of Pediatrics 1960;57:553. - PubMed
Chan‐Ling 1995
-
- Chan‐Ling T, Gock B, Stone J. Supplemental oxygen therapy. Basis for noninvasive treatment of retinopathy of prematurity. Investigative Ophthalmology and Visual Science 1995;36:1215‐30. - PubMed
Duc 1992
-
- Duc G, Sinclair JC. Oxygen administration. In: Sinclair JC, Bracken MB editor(s). Effective Care of the Newborn Infant. Oxford: Oxford University Press, 1992:178‐98.
Gunn 1980
-
- Gunn TR, Easdown J, Outerbridge EW, Aranda JV. Risk factors in retrolental fibroplasia. Pediatrics 1980;65:1096‐100. - PubMed
Kinsey 1956
-
- Kinsey V. Retrolental fibroplasia. Cooperative study of retrolental fibroplasia and the use of oxygen. Archives of Ophthalmology 1956;56:481‐543. - PubMed
Kinsey 1977
-
- Kinsey VE, Arnold HJ, Kalina RE, Stern L, Stahlman M, Odell G, Driscoll JM, Elliott JH, Payne J, Patz A. PaO2 levels and retrolental fibroplasia: a report of the cooperative study. Pediatrics 1977;60:655‐68. - PubMed
McDonald 1963
McIntosh 2001
-
- McIntosh N, Marlow N. High or low oxygen saturation for the preterm baby. Archives of Disease in Childhood. Fetal and Neonatal Edition 2001;84:F149‐50. - PubMed
Phelps 1988
-
- Phelps DL. Reduced severity of oxygen‐induced retinopathy in kittens recovered in 28% oxygen. Pediatric Research 1988;24:106‐9. - PubMed
Poets 1998
-
- Poets CF. When do infants need additional inspired oxygen? A review of the current literature. Pediatric Pulmonology 1998;26:424‐8. - PubMed
ROP Committee 1984
ROP Committee 1987
-
- Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. II The classification of retinal detachment. Archives of Ophthalmology 1987;105:906‐12. - PubMed
Shahinian 1978
-
- Shahinian L Jr, Malachowski N. Retrolental fibroplasia: a new analysis of risk factors based on recent cases. Archives of Ophthalmology 1978;96:70‐4. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical